`

Tagged: drug development

Developing Drugs Able to Treat Neurological Disease – Boston Biotech Clinical Research

June 30th, 2020 | drug development

Techniques that bypass or trick the guardian of the central nervous system. Developing drugs that can penetrate into the brain requires some creativity. The approaches vary, each technique comes with its benefits and drawbacks, making it appropriate for some patients or drug types but not others. In some diseases, you might want the drug everywhere; […]

Artificial intelligence Diagnostic tool for COVID-19 and Neurodegenerative Diseases

June 16th, 2020 | drug development

Lesions in the lungs of patients with pneumonia caused by a SARS-CoV-2 infection are distinct from those caused by bacteria. SARS-CoV-2 is known to damage lung tissue as many COVID-19 patients develop pneumonia, which can progress to respiratory failure and sometimes death. In chest CT scans lungs of COVID-19 patients show cloudy lesion patterns that […]

The future of Orphan Drug Clinical Trials

May 4th, 2020 | drug development

Biotech companies’ continued participation in the Global Orphan Drug Market Opportunity requires the development of new strategies rooted in the established knowledge of orphan developer experts. Participation of big pharmaceutical companies in the ongoing clinical research of orphan drug are about to introduce a drastic change in overall scenario of the approach. Global Orphan Drug […]

Our experienced CRO Management and Drug development team identify study remediation strategies and provide a resource for any Study Rescue

December 10th, 2019 | drug development

Every clinical study has its unique challenges that initially may not have been factored for. Experienced management can help sponsors to address prolonged trial timeline and high quality data. Rare Diseases and Precision Medicine Require Unique Approaches In Clinical Trial Design. There could be any number of factors that could necessitate a study being rescued. […]

Cost vs. Value: Can We Have Both?

August 1st, 2019 | drug development

Could Seamless Adaptive Designs Advance Rare Disease Clinical Trial Design?

July 24th, 2019 | drug development

Getting More Drugs Approved for Rare Diseases

July 3rd, 2019 | drug development

Strategic Consulting: The convergence revolution to innovate clinical trial process

May 10th, 2019 | drug development

Strategic Consulting – SCIO Process -A New Way for Drug Development

April 30th, 2019 | drug development

Pin It on Pinterest